These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 2552603

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacodynamic properties of long lasting butyryl heparin derivatives in the rabbit.
    Saivin S, Caranobe C, Petitou M, Lormeau JC, Houin G, Boneu B.
    Thromb Haemost; 1992 May 04; 67(5):550-5. PubMed ID: 1325682
    [Abstract] [Full Text] [Related]

  • 3. A comparison of the antithrombotic effects of heparin and of low molecular weight heparins with increasing antifactor Xa/antifactor IIa ratio in the rabbit.
    Carrie D, Caranobe C, Boneu B.
    Br J Haematol; 1993 Apr 04; 83(4):622-6. PubMed ID: 8390849
    [Abstract] [Full Text] [Related]

  • 4. Pharmacologic properties of an unfractionated heparin butyryl derivative with long-lasting effects.
    Saivin S, Petitou M, Lormeau JC, Dupouy D, Sie P, Caranobe C, Houin G, Boneu B.
    J Lab Clin Med; 1992 Feb 04; 119(2):189-96. PubMed ID: 1740633
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological properties of a low molecular weight butyryl heparin derivative (C4-CY 216) with long lasting effects.
    Saivin S, Petitou M, Lormeau JC, Dupouy D, Sié P, Caranobe C, Houin G, Boneu B.
    Thromb Haemost; 1992 Mar 02; 67(3):346-51. PubMed ID: 1322569
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Oral administration of a microencapsulated low-molecular-weight heparin to rabbits: anti-Xa and anti-IIa profiles.
    Javot L, Sapin A, Scala-Bertola J, Vigneron C, Lecompte T, Maincent P.
    Thromb Haemost; 2010 Jun 02; 103(6):1254-67. PubMed ID: 20390227
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological properties of CY 216 and of its ACLM and BCLM components in the rabbit.
    Peyrou V, Lormeau JC, Caranobe C, Gabaig AM, Crepon B, Saivin S, Houin G, Sié P, Boneu B.
    Thromb Haemost; 1994 Aug 02; 72(2):268-74. PubMed ID: 7831664
    [Abstract] [Full Text] [Related]

  • 12. Comparative human pharmacology of low molecular weight heparins.
    Harenberg J, Stehle G, Augustin J, Zimmermann R.
    Semin Thromb Hemost; 1989 Oct 02; 15(4):414-23. PubMed ID: 2554502
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of the pharmacokinetics of enoxaparin (Clexane) and unfractionated heparin.
    Dawes J.
    Acta Chir Scand Suppl; 1990 Oct 02; 556():68-74. PubMed ID: 1963020
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic and pharmacodynamic characterization of a medium-molecular-weight heparin in comparison with UFH and LMWH.
    Alban S, Welzel D, Hemker HC.
    Semin Thromb Hemost; 2002 Aug 02; 28(4):369-78. PubMed ID: 12244484
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.